Doshi Dipal Insider Trades

Insider Trading History

Track insider trading activity for Doshi Dipal. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $3.46M 526,014 shares
Last Trade
Mar 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$226k 19,181 shares
$11.76
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $3.59M 545,195 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$115k 9,869 shares
$11.66
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $3.65M 555,064 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.14M 347,400 shares
$11.93
$6.58
Azenta
Azenta AZTA
Director
Holding Value $232k 9,703 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158k 5,663 shares
$27.85
$23.89
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.74M 415,664 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$47.4k 8,723 shares
$5.43
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.79M 424,387 shares
Last Trade
Mar 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$205k 17,566 shares
$11.68
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.91M 441,953 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.07M 173,400 shares
$11.94
$6.58
Azenta
Azenta AZTA
Director
Holding Value $96.5k 4,040 shares
Last Trade
Feb 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$211k 4,040 shares
$52.32
$23.89
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.14M 325,753 shares
Last Trade
Sep 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$12.5k 826 shares
$15.13
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.15M 326,579 shares
Last Trade
Sep 04, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$73.2k 4,744 shares
$15.42
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.19M 332,147 shares
Last Trade
Sep 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.7k 3,152 shares
$16.08
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.2M 334,475 shares
Last Trade
Jul 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.5k 1,600 shares
$17.81
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.21M 336,075 shares
Last Trade
Jul 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.4k 300 shares
$18.00
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.21M 336,375 shares
Last Trade
Jun 13, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.2k 1,000 shares
$16.17
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.22M 337,375 shares
Last Trade
May 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.1k 1,200 shares
$15.11
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.23M 338,575 shares
Last Trade
May 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$27k 1,800 shares
$15.00
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.24M 340,375 shares
Last Trade
Mar 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$62k 5,049 shares
$12.28
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.28M 346,815 shares
Last Trade
Mar 04, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$33.1k 2,555 shares
$12.94
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $2.29M 347,979 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 158,500 shares
$13.73
$6.58
Entrada Therapeutics
Entrada Therapeutics TRDA
CEO
Holding Value $1.6M 243,279 shares
Last Trade
Feb 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$15k 1,000 shares
$15.00
$6.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up